- Home
- GLPG vs MAG Comparison
GLPG vs MAG Comparison
Compare GLPG & MAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- MAG
- Stock Information
- Founded
- GLPG 1999
- MAG N/A
- Country
- GLPG Belgium
- MAG Canada
- Employees
- GLPG N/A
- MAG N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- MAG Precious Metals
- Sector
- GLPG Health Care
- MAG Basic Materials
- Exchange
- GLPG Nasdaq
- MAG Nasdaq
- Market Cap
- GLPG 2.0B
- MAG 2.2B
- IPO Year
- GLPG 2005
- MAG N/A
- Fundamental
- Price
- GLPG $32.98
- MAG $20.37
- Analyst Decision
- GLPG Sell
- MAG Hold
- Analyst Count
- GLPG 4
- MAG 3
- Target Price
- GLPG $25.33
- MAG $20.50
- AVG Volume (30 Days)
- GLPG 372.1K
- MAG 1.2M
- Earning Date
- GLPG 07-23-2025
- MAG 08-05-2025
- Dividend Yield
- GLPG N/A
- MAG 1.93%
- EPS Growth
- GLPG N/A
- MAG 57.48
- EPS
- GLPG N/A
- MAG 0.88
- Revenue
- GLPG $323,674,692.00
- MAG N/A
- Revenue This Year
- GLPG $0.78
- MAG N/A
- Revenue Next Year
- GLPG N/A
- MAG N/A
- P/E Ratio
- GLPG N/A
- MAG $23.62
- Revenue Growth
- GLPG 5.43
- MAG N/A
- 52 Week Low
- GLPG $22.36
- MAG $11.29
- 52 Week High
- GLPG $33.86
- MAG $22.66
- Technical
- Relative Strength Index (RSI)
- GLPG 64.82
- MAG 40.09
- Support Level
- GLPG $31.98
- MAG $20.86
- Resistance Level
- GLPG $33.51
- MAG $22.31
- Average True Range (ATR)
- GLPG 0.84
- MAG 0.53
- MACD
- GLPG 0.13
- MAG -0.21
- Stochastic Oscillator
- GLPG 82.68
- MAG 2.75
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which produced around 4,000 tonnes per day commercially. The company is also Interested in the Larder project. Its operations are Juanicipio, Deer Trail, and Larder. The Juanicipio Mine recognizes silver, gold, lead, and zinc revenue from concentrate sales.